Head Lice
Conditions
Brief summary
To establish the therapeutic equivalence and safety of a generic Benzyl Alcohol Lotion 5% with Ulesfia Lotion 5% in eradication of head lice in the study subjects.
Interventions
White topical lotion
White topical lotion
White topical lotion
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy males or non-pregnant females aged 6 month or over with an upper age limit of 60 years. * Prospective participants upon examination are confirmed to have at least 3 live head lice (defined as lice adults or nymphs) and at least 5 viable appearance louse eggs (nits). * Prospective participants who give written informed consent or, if the participant is under 17 years of age, whose parent/guardian gives written informed consent to participate in the study. * Prospective participants who will be available for follow up visits over the 21 days following first treatment. * Prospective female participants (including female caregivers) of childbearing potential who are willing to provide a urine pregnancy test. * Prospective participants who agree not to shave their hair or use any other pediculicide, nit combing, or louse treatment method during the course of the study.
Exclusion criteria
* Prospective participants with a known sensitivity to any of the ingredients in benzyl alcohol lotion 5% (Hi-Tech Pharmacal Inc) or Ulesfia 5% (Shionogi Inc). * Prospective participants with a known history of irritation or sensitivity to pediculicides or hair care products. * Prospective participants with a secondary bacterial infection of the scalp (eg. impetigo/pyoderma) or have a secondary or long term scalp condition that could make it difficult to evaluate the extent and severity of an infestation or that would present a problem in the evaluation of response to therapy (e.g., psoriatic lesions of the scalp, extensive seborrheic dermatitis). * Prospective participants who have been treated with other head lice products within 4 weeks prior to randomization. * Prospective participants who regularly shave their hair, have bleached their hair, used a permanent color on their hair, or their hair has been permanently straightened or waved within the previous 2 weeks. * Prospective participants who have been treated with Trimethoprim containing products within the previous 4 weeks, or who are currently taking such a course. * Females who are pregnant, planning to become pregnant, during the course of the study period, or are currently breast feeding mothers. * Females of childbearing potential who are unwilling to use an adequate method of contraception from at least 4 weeks prior to the first application of treatment and until 4 weeks after the last application of treatment, or who are unwilling to take a urine pregnancy test. * Prospective participants who have participated in another clinical study or used an investigational new drug within 1 month before entry into this study. * Participants who have already participated in this clinical study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants With Infestation Successfully Eliminated by Active Treatment. | Study Day 22 +/-2 | Successful elimination of infestation by active treatment \[Time frame: 22 + 2 days\]. No evidence of active head lice infestation 22 days after enrollment. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Benzyl Alcohol Lotion 5% Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Benzyl Alcohol Lotion 5%: White topical lotion | 107 |
| Ulesfia (Benzyl Alcohol Lotion 5%) Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion | 108 |
| Vehicle Placebo Lotion 0% Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Placebo: White topical lotion | 24 |
| Total | 239 |
Baseline characteristics
| Characteristic | Benzyl Alcohol Lotion 5% | Ulesfia (Benzyl Alcohol Lotion 5%) | Vehicle Placebo Lotion 0% | Total |
|---|---|---|---|---|
| Age, Categorical <=18 years | 77 Participants | 85 Participants | 18 Participants | 180 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 30 Participants | 23 Participants | 6 Participants | 59 Participants |
| Region of Enrollment United States | 107 participants | 108 participants | 24 participants | 239 participants |
| Sex: Female, Male Female | 102 Participants | 98 Participants | 24 Participants | 224 Participants |
| Sex: Female, Male Male | 5 Participants | 10 Participants | 0 Participants | 15 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 107 | 0 / 108 | 0 / 24 |
| other Total, other adverse events | 2 / 107 | 1 / 108 | 0 / 24 |
| serious Total, serious adverse events | 0 / 107 | 0 / 108 | 0 / 24 |
Outcome results
Number of Participants With Infestation Successfully Eliminated by Active Treatment.
Successful elimination of infestation by active treatment \[Time frame: 22 + 2 days\]. No evidence of active head lice infestation 22 days after enrollment.
Time frame: Study Day 22 +/-2
Population: PP
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Benzyl Alcohol Lotion 5% | Number of Participants With Infestation Successfully Eliminated by Active Treatment. | 59 Participants |
| Ulesfia (Benzyl Alcohol Lotion 5%) | Number of Participants With Infestation Successfully Eliminated by Active Treatment. | 57 Participants |
| Vehicle Placebo Lotion 0% | Number of Participants With Infestation Successfully Eliminated by Active Treatment. | 6 Participants |